Send feedback

CEACAM7

gene
On this page

Also known as CEA

Summary

CEACAM7 (CEA cell adhesion molecule 7, HGNC:1819) is a protein-coding gene on chromosome 19q13.2, encoding Cell adhesion molecule CEACAM7 (Q14002).

This gene encodes a cell surface glycoprotein and member of the carcinoembryonic antigen (CEA) family of proteins. Expression of this gene may be downregulated in colon and rectal cancer. Additionally, lower expression levels of this gene may be predictive of rectal cancer recurrence. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 1087 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 47 total
  • GTEx eGene: eQTL in 7 tissues, sQTL in 0 (q < 0.05)
  • Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.37 (unconstrained)
  • MANE Select transcript: NM_001291485

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:1819
Approved symbolCEACAM7
NameCEA cell adhesion molecule 7
Location19q13.2
Locus typegene with protein product
StatusApproved
AliasesCEA
Ensembl geneENSG00000007306
Ensembl biotypeprotein_coding
OMIM619160
Entrez1087

Gene structure

Transcript identifiers

Ensembl transcripts: 21 — 17 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

MANE Select: ENST00000401731

Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 2, TSL 2: 1, TSL 5: 1

ENST00000401731, ENST00000006724, ENST00000599715, ENST00000602225, ENST00000869051, ENST00000869052, ENST00000869053, ENST00000869054, ENST00000869055, ENST00000869056, ENST00000869057, ENST00000869058, ENST00000869059, ENST00000869060, ENST00000869061, ENST00000948635, ENST00000994563, ENST00000994564, ENST00001022527, ENST00001022533, ENST00001134003

RefSeq mRNA: 2 — MANE Select: NM_001291485 NM_001291485, NM_006890

CCDS: CCDS12583

Canonical transcript exons

ENST00000401731 — 5 exons

ExonStartEnd
ENSE000008424664167737641677503
ENSE000015554724168810241688270
ENSE000015609134167330341674739
ENSE000025179164168378541684063
ENSE000034955674168685941687221

Expression profiles

Bgee: expression breadth ubiquitous, 137 present calls, max score 99.62.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.9852 / max 1201.3699, expressed in 35 samples.

Highest expression (Bgee): mucosa of transverse colon, rectum, colonic mucosa, mucosa of sigmoid colon, ileal mucosa.

Genetic regulation across tissues (GTEx eQTL / sQTL)

CEACAM7 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 7 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.

7 significant tissue × QTL associations:

TissueQTLq-valueSlopeLead variant
Esophagus Mucosaeqtl7.3e-34-0.3819:41675017:C:G
Skin Sun Exposed Lower legeqtl2.6e-23+0.4219:41642531:C:A
Skin Not Sun Exposed Suprapubiceqtl4.3e-15+0.3919:41654540:T:TA
Colon Transverseeqtl9.6e-06-0.1519:41662744:T:C
Pancreaseqtl4.9e-04-0.2719:41685453:T:C
Whole Bloodeqtl7.8e-03+0.4519:40774896:G:A
Prostateeqtl1.8e-02+0.4119:41247729:G:A

FANTOM5 promoters

2 alternative TSS:

Promoter IDTPM avgSamples expressed
1810850.857335
1810840.127912

Top tissues by expression

showing 100 of 267 tissues by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of transverse colonUBERON:000499199.62gold quality
rectumUBERON:000105299.61gold quality
colonic mucosaUBERON:000031799.32gold quality
mucosa of sigmoid colonUBERON:000499399.17gold quality
ileal mucosaUBERON:000033193.00gold quality
vermiform appendixUBERON:000115492.61gold quality
transverse colonUBERON:000115791.47gold quality
islet of LangerhansUBERON:000000689.42gold quality
lower esophagus mucosaUBERON:003583489.37gold quality
gall bladderUBERON:000211088.67gold quality
esophagus mucosaUBERON:000246985.96gold quality
caecumUBERON:000115385.29gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.95gold quality
diaphragmUBERON:000110379.56gold quality
palpebral conjunctivaUBERON:000181279.55gold quality
large intestineUBERON:000005979.13gold quality
colonUBERON:000115578.37gold quality
vaginaUBERON:000099677.96gold quality
cervix epitheliumUBERON:000480177.53gold quality
pancreatic ductal cellCL:000207977.32silver quality
epithelium of esophagusUBERON:000197676.26gold quality
oral cavityUBERON:000016775.90gold quality
esophagus squamous epitheliumUBERON:000692075.86gold quality
colonic epitheliumUBERON:000039775.23gold quality
cervix squamous epitheliumUBERON:000692273.79gold quality
epithelial cell of pancreasCL:000008371.26silver quality
olfactory bulbUBERON:000226471.09gold quality
pancreasUBERON:000126470.93gold quality
squamous epitheliumUBERON:000691470.58gold quality
intestineUBERON:000016070.33gold quality
pharyngeal mucosaUBERON:000035570.21gold quality
mucosa of urinary bladderUBERON:000125970.14gold quality
type B pancreatic cellCL:000016967.40gold quality
hair follicleUBERON:000207365.94gold quality
esophagusUBERON:000104365.21gold quality
uterine cervixUBERON:000000264.11gold quality
oviduct epitheliumUBERON:000480463.85gold quality
body of pancreasUBERON:000115063.27gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450262.62gold quality
tongue squamous epitheliumUBERON:000691962.43gold quality
ectocervixUBERON:001224961.17gold quality
jejunal mucosaUBERON:000039960.30gold quality
tonsilUBERON:000237259.87gold quality
deciduaUBERON:000245058.52gold quality
gluteal muscleUBERON:000200058.47gold quality
quadriceps femorisUBERON:000137758.33gold quality
triceps brachiiUBERON:000150958.29gold quality
tongueUBERON:000172358.28silver quality
smooth muscle tissueUBERON:000113558.19gold quality
upper arm skinUBERON:000426358.13gold quality
vastus lateralisUBERON:000137958.12gold quality
skin of abdomenUBERON:000141657.99gold quality
mucosa of paranasal sinusUBERON:000503057.68gold quality
duodenumUBERON:000211457.48gold quality
amniotic fluidUBERON:000017357.30gold quality
epithelium of nasopharynxUBERON:000195157.04gold quality
gingivaUBERON:000182856.84gold quality
urinary bladderUBERON:000125556.50gold quality
mammary ductUBERON:000176556.46gold quality
epithelium of mammary glandUBERON:000324456.10gold quality
muscle layer of sigmoid colonUBERON:003580556.05gold quality
zone of skinUBERON:000001455.68gold quality
skin of legUBERON:000151155.30gold quality
right coronary arteryUBERON:000162555.16gold quality
jejunumUBERON:000211554.64gold quality
thymusUBERON:000237053.84gold quality
superior surface of tongueUBERON:000737153.34gold quality
mouth mucosaUBERON:000372952.97gold quality
minor salivary glandUBERON:000183052.84gold quality
endothelial cellCL:000011552.81gold quality
deltoidUBERON:000147652.78gold quality
gingival epitheliumUBERON:000194952.63gold quality
muscle tissueUBERON:000238552.22gold quality
fallopian tubeUBERON:000388952.21gold quality
substantia nigra pars reticulataUBERON:000196652.15gold quality
Brodmann (1909) area 46UBERON:000648351.77gold quality
heart right ventricleUBERON:000208051.76gold quality
upper leg skinUBERON:000426251.76gold quality
saliva-secreting glandUBERON:000104451.28gold quality
orbitofrontal cortexUBERON:000416750.54gold quality
kidney epitheliumUBERON:000481950.25gold quality
myocardiumUBERON:000234950.22gold quality
CA1 field of hippocampusUBERON:000388150.18gold quality
substantia nigra pars compactaUBERON:000196549.96gold quality
nasal cavity mucosaUBERON:000182649.79gold quality
lateral nuclear group of thalamusUBERON:000273649.56gold quality
cardiac muscle of right atriumUBERON:000337949.29gold quality
blood vessel layerUBERON:000479749.29gold quality
bone marrowUBERON:000237149.12gold quality
skin of hipUBERON:000155448.97silver quality
choroid plexus epitheliumUBERON:000391148.89gold quality
left ventricle myocardiumUBERON:000656648.24gold quality
biceps brachiiUBERON:000150748.09gold quality
olfactory segment of nasal mucosaUBERON:000538648.07gold quality
inferior olivary complexUBERON:000212747.56gold quality
nephron tubuleUBERON:000123147.52gold quality
periodontal ligamentUBERON:000826647.14gold quality
urethraUBERON:000005746.99silver quality
renal glomerulusUBERON:000007446.99gold quality
metanephric glomerulusUBERON:000473646.96gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-GEOD-83139yes3529.05
E-GEOD-125970yes2283.47
E-ANND-3yes13.54

HPA expression

RNA tissue specificity: Tissue enriched

31 HPA tissues / cells by nTPM:

Tissue / cellAxisnTPMProtein (IHC)
Rectumtissue612.7medium
Colontissue559.1medium
Appendixtissue67.5medium
Esophagustissue49.4not detected
Gallbladdertissue37.0not detected
Vaginatissue34.4not detected
Urinary bladdertissue21.9not detected
Tonsiltissue11.3not detected
Smooth muscletissue5.3not detected
Stomach 1tissue1.9low
Pancreastissue1.4not detected
Skin 1tissue1.3low
Seminal vesicletissue0.7low
Cervixtissue0.6not detected
Adipose tissuetissue0.5not detected
Duodenumtissue0.5low
Kidneytissue0.4medium
Fallopian tubetissue0.4not detected
Breasttissue0.3medium
Endometrium 1tissue0.3not detected
Spleentissue0.2not detected
Testistissue0.1not detected
Salivary glandtissue0.1low
Skeletal muscletissue0.1not detected
Prostatetissue0.1not detected
Bone marrowtissue0.1not detected
Heart muscletissue0.0low
Parathyroid glandtissue0.0medium
Epididymistissue0.0medium
Placentatissue0.0low
Small intestinetissue0.0low

Brain sub-regions (HPA Brain Atlas): detected in 2; highest nTPM — Endometrium 2 (-1.0), Stomach 2 (-1.0).

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): GLI2

miRNA regulators (miRDB)

Targeting CEACAM7 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).

showing 30 of 59 miRNAs:

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4481100.0066.421669
HSA-MIR-103A-3P99.9869.141595
HSA-MIR-10799.9869.141595
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-391099.9571.132227
HSA-MIR-311999.9271.342390
HSA-MIR-430299.8967.941187
HSA-MIR-544A99.8468.661965
HSA-MIR-4668-5P99.7970.583782
HSA-MIR-200A-5P99.7669.10949
HSA-MIR-200B-5P99.7669.05948
HSA-MIR-6512-3P99.6566.071468
HSA-MIR-6720-5P99.6566.221459
HSA-MIR-130399.6569.771662
HSA-MIR-205399.5769.151635
HSA-MIR-1252-3P99.5567.712862
HSA-MIR-154-3P99.5070.05831
HSA-MIR-487A-3P99.5069.95840
HSA-MIR-548G-3P99.4868.672159
HSA-MIR-312399.4767.152693
HSA-MIR-6839-3P99.3968.861301
HSA-MIR-94099.3766.142064
HSA-MIR-431199.3170.473041
HSA-MIR-6808-5P99.3166.232150
HSA-MIR-6893-5P99.3166.252119
HSA-MIR-329-5P99.2768.111597
HSA-MIR-10522-5P99.2668.502087
HSA-MIR-426399.1869.252236
HSA-MIR-450499.1069.141328

Functional genomics

gnomAD constraint: pLI 2.22e-08, LOEUF 1.37, missense Z 0.264 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD

Regional missense constraint (gnomAD RMC): no regional variation along ENST00000401731 — one region, missense o/e 0.98.

Literature-anchored findings (GeneRIF, showing 6)

  • CGM2 RT-PCR assay provides no specific prognostic information and cannot be used as a decision criterion for adjuvant therapy after colorectal cancer surgery. (PMID:16627067)
  • CEACAM-7 expression is significantly decreased in rectal cancer; a potential tumor marker (PMID:20004437)
  • High CEACAM7 is associated with gastric carcinoma. (PMID:22195770)
  • crystal structure of the N-terminal dimerization domain of CEACAM has been determined at 1.47 A resolution (PMID:26323304)
  • CEACAM7 expression is significantly upregulated in human masticatory mucosa during wound healing (PMID:28005267)
  • CEACAM7 polymorphisms predict genetic predisposition to mortality in post-surgical septic shock patients. (PMID:34657826)

Cross-species orthologs

36 orthologs

OrganismSymbolGene ID
mus_musculusPsg18ENSMUSG00000003505
mus_musculusPsg17ENSMUSG00000004540
mus_musculusPsg19ENSMUSG00000004542
mus_musculusCeacam5ENSMUSG00000008789
mus_musculusPsg29ENSMUSG00000023159
mus_musculusCeacam14ENSMUSG00000023185
mus_musculusCeacam12ENSMUSG00000030366
mus_musculusCeacam11ENSMUSG00000030368
mus_musculusPsg28ENSMUSG00000030373
mus_musculusPsg22ENSMUSG00000044903
mus_musculusCeacam3ENSMUSG00000053228
mus_musculusCeacam10ENSMUSG00000054169
mus_musculusCeacam2ENSMUSG00000054385
mus_musculusCeacam13ENSMUSG00000057195
mus_musculusPsg20ENSMUSG00000063305
mus_musculusPsg16ENSMUSG00000066760
mus_musculusPsg21ENSMUSG00000070796
mus_musculusPsg27ENSMUSG00000070797
mus_musculusPsg25ENSMUSG00000070798
mus_musculusPsg26ENSMUSG00000070799
mus_musculusCeacam1ENSMUSG00000074272
mus_musculusPsg23ENSMUSG00000074359
mus_musculusCeacam23ENSMUSG00000078793
rattus_norvegicusLOC102557244ENSRNOG00000017519
rattus_norvegicusCeacam11ENSRNOG00000017620
rattus_norvegicusCeacam1ENSRNOG00000020578
rattus_norvegicusPsgb1ENSRNOG00000027288
rattus_norvegicusCeacam3ENSRNOG00000027607
rattus_norvegicusPsg29ENSRNOG00000029485
rattus_norvegicusLOC120098290ENSRNOG00000034000
rattus_norvegicusPsg19ENSRNOG00000038101
rattus_norvegicusCeacam12ENSRNOG00000042158
rattus_norvegicusCeacam4ENSRNOG00000046222
rattus_norvegicusPsg16ENSRNOG00000062379
rattus_norvegicusCgm4ENSRNOG00000062787
rattus_norvegicusLOC102557319ENSRNOG00000071114

Paralogs (24): CEACAM21 (ENSG00000007129), CEACAM1 (ENSG00000079385), CEACAM6 (ENSG00000086548), CEACAM4 (ENSG00000105352), CEACAM5 (ENSG00000105388), PSG8 (ENSG00000124467), CEACAM8 (ENSG00000124469), HEPACAM (ENSG00000165478), PSG6 (ENSG00000170848), CEACAM3 (ENSG00000170956), PSG9 (ENSG00000183668), CEACAM19 (ENSG00000186567), HEPACAM2 (ENSG00000188175), PSG5 (ENSG00000204941), CEACAM18 (ENSG00000213822), CEACAM16 (ENSG00000213892), VSTM5 (ENSG00000214376), PSG3 (ENSG00000221826), PSG7 (ENSG00000221878), PSG1 (ENSG00000231924), PSG2 (ENSG00000242221), PSG11 (ENSG00000243130), PSG4 (ENSG00000243137), CEACAM20 (ENSG00000273777)

Mouse-model phenotypes

Observed phenotypes of the mouse ortholog (MGI:1347251) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 51 distinct phenotype terms.

Mouse phenotype (MP)Records
increased circulating insulin level2
decreased mean corpuscular hemoglobin concentration2
decreased susceptibility to Coronaviridae infection2
increased leukocyte cell number1
abnormal colon morphology1
obese1
polyphagia1
increased circulating HDL cholesterol level1
decreased litter size1
abnormal coat/hair pigmentation1
abnormal glucose homeostasis1
decreased susceptibility to viral infection1
abnormal T cell physiology1
increased mean platelet volume1
decreased circulating triglyceride level1
abnormal cytokine secretion1
decreased circulating chloride level1
increased insulin secretion1
increased lean body mass1
increased incidence of tumors by chemical induction1
abnormal vascular wound healing1
decreased energy expenditure1
decreased T cell number1
decreased T cell proliferation1
decreased circulating cholesterol level1

+26 more (showing top 25).

Genomic neighbors (locus context)

Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).

SymbolTypeEntrez
CEACAM4protein-coding1089
CEACAM3protein-coding1084
CEACAM6protein-coding4680
CEACAM5protein-coding1048

Protein

Protein identifiers

Cell adhesion molecule CEACAM7 — Q14002 (reviewed: Q14002)

Alternative names: Carcinoembryonic antigen CGM2, Carcinoembryonic antigen-related cell adhesion molecule 7

All UniProt accessions (2): Q14002, A0A0A0MTT6

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Homodimer.

Subcellular location. Cell membrane. Apical cell membrane.

Tissue specificity. Expressed in columnar epithelial cells of the colon (at protein level). Strongly down-regulated in colonic adenocarcinomas.

Similarity. Belongs to the immunoglobulin superfamily. CEA family.

Isoforms (2)

UniProt IDNamesCanonical?
Q14002-12ayes
Q14002-22b

RefSeq proteins (2): NP_001278414, NP_008821 (=MANE)

Domains & families (InterPro)

IDNameType
IPR003599Ig_subDomain
IPR007110Ig-like_domDomain
IPR013106Ig_V-setDomain
IPR013783Ig-like_foldHomologous_superfamily
IPR036179Ig-like_dom_sfHomologous_superfamily
IPR050831CEA_cell_adhesionFamily

Pfam: PF07686, PF13927

UniProt features (33 total): strand 8, glycosylation site 7, sequence variant 3, sequence conflict 3, helix 3, domain 2, signal peptide 1, chain 1, disulfide bond 1, splice variant 1, propeptide 1, turn 1, lipid moiety-binding region 1

Structure

Experimental structures (PDB)

1 structures by resolution:

PDBTitleMethodResolution (Å)
4Y89Crystal structure of the N-terminal domain of CEACAM7X-RAY DIFFRACTION1.47

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q14002-F184.920.69

Human Protein Atlas

Protein class: Predicted membrane proteins

Protein evidence: Evidence at protein level

Subcellular location (HPA, imaging): plasma membrane; cytosol

Antibody reliability (HPA): IH enhanced · IF supported

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1)

TypePositions
Gpi-anchor amidated serine242

Disulfide bonds (1)

TypePositions
Disulfide bond168–216

Glycosylation sites (7)

TypePositions
N-linked (glcnac…) asparagine174, 183, 198, 57, 85, 105, 112

Function

Pathways and Gene Ontology

Reactome pathways

1 curated (TAS) of 3; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).

3 pathways:

IDPathwayEvidence
R-HSA-163125Post-translational modification: synthesis of GPI-anchored proteinscurated
R-HSA-392499Metabolism of proteins—
R-HSA-597592Post-translational protein modification—

MSigDB gene sets: 88 (showing top): GOCC_CELL_SURFACE, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, GOCC_APICAL_PLASMA_MEMBRANE, MODULE_113, SABATES_COLORECTAL_ADENOMA_DN, GOCC_APICAL_PART_OF_CELL, GOCC_SIDE_OF_MEMBRANE, GOCC_PLASMA_MEMBRANE_REGION, GOMF_KINASE_BINDING, GOMF_PROTEIN_TYROSINE_KINASE_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, RICKMAN_HEAD_AND_NECK_CANCER_E, BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE, REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS

GO Biological Process (2): regulation of immune system process (GO:0002682), signal transduction (GO:0007165)

GO Molecular Function (1): protein tyrosine kinase binding (GO:1990782)

GO Cellular Component (5): extracellular region (GO:0005576), plasma membrane (GO:0005886), cell surface (GO:0009986), apical plasma membrane (GO:0016324), side of membrane (GO:0098552)

Reactome top-level categories

2 top-level categories:

CategoryPathways
Post-translational protein modification1
Metabolism of proteins1

GO top-level categories

14 GO namespaces:

CategoryTerms
cellular anatomical structure3
membrane2
immune system process1
regulation of biological process1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
protein kinase binding1
cell periphery1
apical part of cell1
plasma membrane region1
leaflet of membrane bilayer1

Experimentally-supported GO annotations

GO terms backed by direct experimental evidence (ECO experimental codes) — 2 of 8 annotations. The rest are phylogenetic / computational / electronic (IEA).

2 experimentally-supported GO terms:

GO termNSEvidence
apical plasma membraneCCdirect assay
plasma membraneCCdirect assay

Protein interactions and networks

STRING

showing 15 of 490 interactions by confidence (×1000):

Protein AProtein BPartner UniProtScore
CEACAM7CYP2A13Q16696560
CEACAM7CYP2A7P20853539
CEACAM7CYP2A6P00190451
CEACAM7ZNF574Q6ZN55426
CEACAM7CD177Q8N6Q3396
CEACAM7CEACAM19Q7Z692386
CEACAM7GRB14Q14449370
CEACAM7BCL10O95999365
CEACAM7CARD9Q9H257363
CEACAM7A1BGP04217360
CEACAM7TCN1P20061310
CEACAM7DSC2Q02487306
CEACAM7OTOP2Q7RTS6303
CEACAM7GUCA2AQ02747300
CEACAM7ZNF526Q8TF50299

IntAct

Human interaction partners of CEACAM7 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).

4 partners by confidence:

PartnerInteraction typeMIscoreRecords
CEACAM1physical association0.4001
CEACAM6physical association0.4001
GPC1physical association0.4001
PBRM1physical association0.4001

BioGRID (7 interactions; top human partners by supporting records): CEACAM1 (Reconstituted Complex), CEACAM6 (Reconstituted Complex), GPC1 (Affinity Capture-MS), PBRM1 (Affinity Capture-MS), PSG3 (Negative Genetic), PSG6 (Negative Genetic)

Disease & clinical

Genetic variants

Variant evidence for CEACAM7: 47 ClinVar records (0 pathogenic / likely pathogenic).

ClinVar

47 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance41
Likely benign3
Benign0

SpliceAI

Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 29 predictions of 360):

Position(s)EffectΔscoreSites
19:41674761acceptor_gain1.0000
19:41684066acceptor_gain0.9900
19:41688100–41688101donor_loss0.99005
19:41683780donor_loss0.98002
19:41683783–41683784donor_loss0.98005
19:41686854donor_loss0.9800
19:41686857–41686858donor_loss0.98005
19:41687222–41687223acceptor_loss0.98006
19:41677509acceptor_gain0.9700
19:41683779–41683780donor_loss0.97002

AlphaMissense

283 missense substitutions predicted likely pathogenic (of 1,724 scored), across 99 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:

ResidueLikely-pathogenic substitutionsMean am_pathogenicityMax am_pathogenicity
D11780.8570.924
C16870.9630.982
W6770.9560.992
C21670.9440.983
W17970.9190.982
D21070.7040.790
S22760.9350.979
G9360.9340.970
G7060.8620.938
P4260.7350.828
Y12150.9100.980
F13950.8980.951
Y6850.8960.960
Y21450.8780.963
P14850.7720.912
K6950.7680.923
G4850.7430.872
G8140.9030.931
G10640.8970.949
I7940.8560.939

HPA cancer prognostics

RNA cancer specificity: Cancer enhanced (Colon Adenocarcinoma, Rectum Adenocarcinoma)

Disease associations

OMIM: gene MIM:619160 | disease phenotypes:

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (CPIC guideline: no)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
Nickeldecreases expression2
ethyl-p-hydroxybenzoatedecreases expression1
sodium arsenitedecreases expression1
1,2-dielaidoylphosphatidylethanolaminedecreases expression1
Zoledronic Acidincreases expression1
Air Pollutantsincreases expression, increases abundance1
Benzo(a)pyreneaffects methylation1
Estradioldecreases expression1
Malathiondecreases expression1
Ozoneincreases abundance, increases expression1
Silicon Dioxidedecreases expression1
Tobacco Smoke Pollutionaffects expression1
Tretinoinincreases expression1

Clinical trials (associated diseases)

Via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.